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ABSTRACT
Objectives: To investigate patient characteristics of an
unselected primary care population associated with risk
of first hospital admission and readmission for acute
exacerbation of chronic obstructive pulmonary disease
(AECOPD).
Design: Retrospective open cohort using
pseudonymised electronic primary care data linked to
secondary care data.
Setting: Primary care; Lothian (population
approximately 800 000), Scotland.
Participants: Data from 7002 patients from 72
general practices with a COPD diagnosis date between
2000 and 2008 recorded in their primary care record.
Patients were followed up until 2010, death or they left
a participating practice.
Main outcome measures: First and subsequent
admissions for AECOPD (International Classification of
Diseases (ICD) 10 codes J44.0, J44.1 in any
diagnostic position) after COPD diagnosis in primary
care.
Results: 1756 (25%) patients had at least 1 AECOPD
admission; 794 (11%) had at least 1 readmission and
the risk of readmission increased with each admission.
Older age at diagnosis, more severe COPD, low body
mass index (BMI), current smoking, increasing
deprivation, COPD admissions and interventions for
COPD prior to diagnosis in primary care, and
comorbidities were associated with higher risk of first
AECOPD admission in an adjusted Cox proportional
hazards regression model. More severe COPD and
COPD admission prior to primary care diagnosis were
associated with increased risk of AECOPD readmission
in an adjusted Prentice-Williams-Peterson model. High
BMI was associated with a lower risk of first AECOPD
admission and readmission.
Conclusions: Several patient characteristics were
associated with first AECOPD admission in a primary
care cohort of people with COPD but fewer were
associated with readmission. Prompt diagnosis in
primary care may reduce the risk of AECOPD
admission and readmission. The study highlights the
important role of primary care in preventing or delaying
a first AECOPD admission.
Strengths and limitations of this study
▪ Chronic obstructive pulmonary disease (COPD)
is largely managed in primary care and our
study uses high-quality routine primary care data
for all patients with COPD diagnosed in primary
care in participating general practices, and there-
fore reflects the characteristics of patients in the
population with COPD.
▪ The primary care data were enriched through
linkage to secondary care admissions data, death
data, cancer registrations and a spirometry data-
base to establish a novel comprehensive pseudo-
nymised data set with over 25 000 person years
of follow-up.
▪ We identified separate risk factors for first and
subsequent admissions after primary care diag-
nosis which helps to explain the conflicting
results observed in other studies that have not
differentiated between first and subsequent
admissions.
▪ Using routine data does have some limitations
such as dealing with missing data; however, sen-
sitivity analyses were carried out to check the
effect of missing primary care data.
▪ It was not possible to investigate variables that
are not recorded routinely, such as support from
carers and family members, which may affect
admission risk.
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INTRODUCTION
Hospital admission for chronic obstructive pulmonary
disease (COPD) is a signiﬁcant burden on healthcare
resources and readmission rates are high. COPD is the
second most common reason for emergency hospital
admission in the UK. Acute exacerbations of COPD
(AECOPD) are responsible for the majority of the
disease burden,1 contribute to the progressive decline in
lung function2 and reduce patients’ quality of life.3
Although patients with very severe exacerbations may
need to be admitted to hospital, COPD admissions are
considered to be ‘potentially preventable’. In recent
years, there has been a policy emphasis on shifting the
balance of care for long-term conditions from secondary
to primary care. Reducing hospital admission rates for
‘ambulatory care sensitive’ conditions, such as COPD, is
one of the main goals of this policy shift.
There is considerable inconsistency in the literature
regarding patient characteristics associated with risk of
AECOPD hospital admission and readmission.4 These
inconsistencies result from differences in study design
used, confounders adjusted for and the population
studied. Evidence from primary care populations is
scarce. Primary care-based studies have not distinguished
between ﬁrst and subsequent admissions after diagno-
sis,5 or have looked at ﬁrst admission and death as a
joint outcome.6 Studies that have distinguished between
a ﬁrst admission7 and a readmission8 9 have used
hospital-based populations. In some studies, patients
were predominantly men.5 7 10 These hospital-based
studies may not be representative of the wider COPD
population.
As COPD is now managed predominantly in primary
care, we aimed to investigate patient characteristics asso-
ciated with risk of ﬁrst AECOPD hospital admission and
readmission, after primary care COPD diagnosis, in a
representative primary care patient population. Our
ability to link electronic primary care data pseudonym-
ously to high-quality routine admissions data made this
possible.
METHODS
Primary care COPD cohort
Primary care general practices in the Lothian Health
Board area of Scotland (population approximately
800 000) that used General Practice Administration
System for Scotland (GPASS) software to hold patient
data were invited to participate in the study. Data were
extracted from 72 of 103 eligible practices by remote
electronic access. Patients were included in the cohort if
they had a diagnostic Read code for COPD ﬁrst
recorded in their electronic health record between 1
April 2000 and 31 March 2008. Date of ﬁrst recorded
COPD Read code in primary care was used as a proxy
for date of diagnosis (see online supplementary
appendix table A1). Patients were excluded if they were
under 35 years of age at date of diagnosis. Patients were
followed up until they left a participating practice, death
or 31 March 2010, whichever was sooner. Primary care
clinical data were separated from patient identiﬁable
data to protect patient conﬁdentiality during linkage
and analysis; both data sets retained a unique pseudony-
mised ID to enable linkage.
Linked data set
The data linkage team at the Information Services
Division (ISD) of National Health Service (NHS)
National Services Scotland (NHS NSS) used the unique
Community Health Index (CHI) number to link
primary care patients to the national Acute Cancer
Deaths and Mental Health (ACaDMe) linked data set.
The ACaDMe data set contains hospital admissions
(Scottish morbidity record; SMR01), cancer registrations
(SMR06) and death data (National Records of Scotland;
NRS). International Classiﬁcation of Diseases (ICD) 9
and ICD10 codes for relevant hospital admissions
(AECOPD, COPD and comorbidities) are speciﬁed in
the online supplementary appendix table A2.
Additional spirometry and smoking data were
extracted from a hospital spirometry database (Royal
Inﬁrmary and Western General Hospitals, Edinburgh).
This data set was linked to the primary care data set
using probability matching of patient identiﬁable vari-
ables (name, sex, date of birth, postcode, CHI number).
Speciﬁcity and sensitivity for the linkage methods used
by ISD are thought to be close to 100% when full identi-
ﬁers are present (name, date of birth, sex, postcode,
CHI). Even when limited identiﬁers have been used
(date of birth, sex, postcode) up to 98.1% precision and
99.5% sensitivity in linkage has been achieved (C
Morris, personal communication, 2015).
Deprivation was assessed using the Scottish Index of
Multiple Deprivation 2009 (SIMD2009), an area-based
measure. Lothian deprivation quintiles were determined
from patients’ postcodes.
Patient identiﬁable data were removed to create a
pseudonymised linked database that was released to the
research team for analysis.
Patient characteristics
Patient characteristics investigated were age at diagnosis,
sex, deprivation, disease severity (based on Global
Initiative for Chronic Obstructive Lung Disease (GOLD)
category),11 body mass index (BMI), smoking status,
asthma, other respiratory comorbidities (history of pneu-
monia, respiratory failure, cor pulmonale), non-
respiratory comorbidity (cancer, chronic kidney disease,
liver disease, dementia, depression, coronary heart
disease, heart failure, stroke, hypertension, diabetes and
osteoporosis), prior COPD interventions and prior
COPD admissions (prior to diagnosis in primary care;
see online supplementary appendix tables A1–A3), and
travel time to hospital. Baseline was deﬁned as date of
COPD diagnosis in primary care records; closest mea-
surements to baseline were used in the analysis with the
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exception of deprivation and travel time to hospital
which were based on most recent patient postcode
recorded. Baseline measurements were used to reduce
the risk of introducing immortal time bias. Categorical
variables were described by the number and percentage
of patients in each category. Continuous variables were
described by the mean and SD.
We acknowledged that some patients have had a
COPD admission (see online supplementary appendix
table A2) prior to diagnosis in primary care. As this may
reﬂect a delay in diagnosis, this was explored as an inde-
pendent risk factor for admission after diagnosis. The
results of this study, therefore, should be interpreted as
risks for ﬁrst AECOPD admission and readmission after
primary care diagnosis.
Outcomes
Primary outcomes were ﬁrst and subsequent AECOPD
hospital admissions after primary care diagnosis date
(ICD10 codes J44.0, J44.1 in any diagnostic position).
Median follow-up time was calculated using the reverse
Kaplan-Meier estimate.12
Patients were at risk of readmission from date of dis-
charge of previous AECOPD admission. Admissions
occurring within 14 days of discharge from previous
AECOPD admission were excluded. Secondary outcomes
were general practitioner (GP)-treated exacerbations
(see online supplementary appendix table A3) and
death.
First AECOPD hospital admission
Kaplan-Meier13 survival curves and log-rank tests were
used for univariate analysis of association of baseline
patient characteristics with time to ﬁrst hospital admis-
sion for AECOPD (data not shown).
Time to ﬁrst AECOPD hospital admission from date
of diagnosis in primary care was analysed using a Cox
proportional hazards regression model.14 Variables for
the model were identiﬁed on the basis of results of uni-
variate analysis and a priori knowledge. Baseline
characteristics (table 1) were entered into the model
and were categorical except for age, which was continu-
ous and standardised. The proportional hazards assump-
tion was evaluated for each variable by visual inspection
of the log-minus-log plots across the covariate categories
and by analysing residuals.
AECOPD readmission
AECOPD readmissions were modelled using a
Prentice-Williams-Peterson (PWP) recurrent event
model, an extension of Cox regression which conditions
on the occurrence of the preceding event in the analysis
of each recurrent event.15 For up to 10 AECOPD admis-
sions per patient (only 34 patients had 11 or more
admissions), we modelled associations between each cov-
ariate and ﬁrst AECOPD admission/readmissions.
Likelihood ratio tests showed that associations were
similar across admissions 2–10 but differed for ﬁrst
admissions (data not shown). A PWP model was, there-
fore, ﬁtted to data for AECOPD admissions 2–10, for
which the reporting of the common HR would be mean-
ingful. The proportional hazards assumption was evalu-
ated for each variable by visual inspection of the
Kaplan-Meier curves across the covariate categories. The
assumption of linearity for age was also tested.
Missing data
A small number of patients (69, 1%) were missing post-
code and hence deprivation quintile; these individuals
were omitted from modelling of outcomes.
Exploratory analysis indicated that missing COPD
severity, BMI and smoking status could not be assumed
to be missing completely at random; ‘missing’ was there-
fore retained as a separate category for modelling.
Sensitivity analysis
A sensitivity analysis for time to ﬁrst AECOPD admission
excluded patients with missing COPD severity, BMI and
smoking status. To account for practice clustering, we
ﬁtted a term for clustering ﬁtted as a random effect
(frailty term) in the Cox proportional hazards model.
Table 1 Baseline characteristics for patients in cohort
Characteristic at diagnosis of COPD
in primary care
Cohort
(n=7002)
n Per cent
Sex
Male 3585 51.2
Deprivation
Quintile 1 (most deprived) 2199 31.4
Quintile 2 1789 25.5
Quintile 3 1367 19.5
Quintile 4 999 14.3
Quintile 5 (least deprived) 648 9.3
COPD severity (% predicted forced expiratory volume)
Mild (≥80) 781 11.2
Moderate (≥50 and <80) 3203 45.7
Severe (≥30 and <50) 1516 21.7
Very severe (<30) 357 5.1
Unknown 1145 16.4
Body mass index (kg/m2)
Low (≥12 and <20) 754 10.8
Normal (≥20 and <25) 1894 27.0
High (≥25) 3106 44.4
Unknown 1248 17.8
Smoking status
Current smoker 4003 57.2
Not current smoker 2431 34.7
Never smoked 274 3.9
Unknown 294 4.2
Asthma comorbidity 1061 15.2
Other respiratory comorbidity 530 7.6
Non-respiratory comorbidity 2524 36.0
Prior admission with COPD 1482 21.2
Prior intervention for COPD 3469 49.5
COPD, chronic obstructive pulmonary disease.
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Statistical software
Data were analysed using IBM SPSS Statistics for
Windows V.20, R for Windows V.2.13.1 and SAS System
for Windows V.9.3 (SAS Institute Inc, Cary, North
Carolina, USA).
RESULTS
Patient characteristics
Table 1 shows baseline characteristics of the patients in
the cohort (n=7002). The mean age at diagnosis was
67.1 years (SD 11.4); there were similar numbers of men
and women and over half of the patients (57%) were
resident in the two most deprived quintiles in Lothian
(quintiles 1 and 2). A high proportion of the patients
(67%) had at least one comorbidity at time of diagnosis.
Almost half (49%) had received treatment for COPD
prior to diagnosis in primary care and 21% had a hos-
pital admission where COPD had been recorded prior
to diagnosis in primary care. Mean per cent predicted
forced expiratory volume in 1 s (FEV1) was 59% (SD
18.8) and mean BMI was 26.3 kg/m2 (SD 6.1).
The median follow-up time for the cohort was 4.5 years
(95% CI 4.3 to 4.6). The event rate was 126.6 (95% CI
122.7 to 130.7) per 1000 patient years for all AECOPD
admissions after primary care diagnosis (table 2).
First AECOPD admission after diagnosis
In total, 1756 patients (25%) had at least one AECOPD
admission. Nine hundred and ﬁfty-ﬁve (14%) patients
were censored due to death, 958 (14%) patients were
censored due to leaving a participating general practice
and 3333 (48%) were censored at the end of study.
Table 3 presents the unadjusted and fully adjusted
modelling of time to ﬁrst AECOPD admission. Older
age, increasing disease severity (or unknown severity),
low BMI (or unknown BMI), current smoking,
comorbidity (excluding asthma), prior intervention for
COPD and prior COPD admission were all associated
with an increased risk of ﬁrst AECOPD admission after
diagnosis in the adjusted model. Decreasing deprivation
(quintiles 3–5) and high BMI were associated with a
reduced risk of ﬁrst AECOPD admission in the adjusted
model. We did not ﬁnd a signiﬁcant association between
travel time to hospital and risk of AECOPD admission
(data not shown).
Sensitivity analyses excluding patients with missing
data for BMI, smoking status or severity showed little
impact on the HRs or 95% CIs. Accounting for practice
clustering by including a frailty term in the model made
little difference to the HRs and 95% CIs (see online
supplementary appendix table A4).
Readmission
There was a high rate of readmission in the cohort: 794
patients (51% of those at risk of further admissions) had
at least one readmission (median number of admis-
sions=3; IQR 2–4).
The risk of readmission accelerated with each
AECOPD admission (ﬁgure 1) with progressive shorten-
ing of the median time to the next admission (table 4).
Table 5 presents the unadjusted and fully adjusted
PWP modelling of time to AECOPD readmission. In
general, the HRs were closer to one than in the model
for time to ﬁrst AECOPD admission. Only greater COPD
severity (or unknown severity) and COPD hospital
admission prior to diagnosis remained statistically signiﬁ-
cantly associated with an increased risk of AECOPD
readmission in the fully adjusted model. High BMI
remained signiﬁcantly associated with a decreased risk
of AECOPD readmission.
Table 2 Summary of outcomes, follow-up and event rates for patients in the cohort
Outcome
Number (%) of
patients with
outcome
Events Follow-up
Event rate per 1000
person years (95% CI)
Total
number of
events
Range
per
person
Median time in
years (95% CI)*
Total
person
years
First admission for
AECOPD
1756 (25.1) 1756 NA 4.5 (4.3 to 4.6) 27377.8 64.1 (61.2 to 67.2)
All admissions for
AECOPD†
1756 (25.1) 3937 1–31 4.5 (4.3 to 4.6) 31088.9 126.6 (122.7 to 130.7)
Readmission within
14 days of previous
discharge
235 (3.4) 448 1–25
Death 1820 (26.0) 1820 NA 5.1 (5.0 to 5.2) 31088.9 58.5 (55.9 to 61.3)
GP-treated
AECOPD‡
2718 (38.8) 10 399 1–48 5.2 (5.1 to 5.4) 31088.9 334.5 (328.1 to 341.0)
*Estimation of median follow-up time using the reverse Kaplan-Meier method.
†Readmissions for AECOPD occurring within 14 days of discharge from a previous AECOPD admission were not considered to be new
admissions and were not included in the modelling.
‡GP-treated exacerbation defined as prescriptions of antibiotics (amoxicillin, cefalexin, ciprofloxacin, clarithromycin, co-amoxiclav, doxycycline
or erythromycin) and oral prednisolone within 7 days of each other and more than 21 days since a previous prescription.
AECOPD, acute exacerbation of chronic obstructive pulmonary disease; GP, general practitioner; NA, not applicable.
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DISCUSSION
In this primary care population, more patient character-
istics were associated with risk of ﬁrst AECOPD admission
than readmission, and associations were stronger for a
ﬁrst admission than a readmission. Only COPD admis-
sion prior to diagnosis in primary care and increased (or
unknown) severity at diagnosis were predictors of both
ﬁrst AECOPD admission and readmission. High BMI was
the only modiﬁable characteristic associated with
reduced risk of both ﬁrst AECOPD admission and
readmission. These results suggest that there is greater
potential for primary care to prevent or delay the initial
admission through appropriate disease management.
This highlights the critical role primary care plays in man-
aging patients with COPD. Readmission rates were high
and we saw acceleration in readmission risk with succes-
sive admissions. Severe exacerbations contribute to
decline in lung function.2 However, risk of readmission
may also in part be inﬂuenced by the patient and/or
GP’s expectation of an admission based on the patient’s
previous admission history.
To the best of our knowledge, this is the ﬁrst study to
compare separately patient characteristics associated
with risk of ﬁrst AECOPD admission and readmission
for a representative primary care-based population using
patient-level data. The existing evidence base for patient
characteristics associated with admission is conﬂicting,
due to different study designs and populations studied.
As more emphasis is being placed on managing COPD
in the community, it is important to understand the risk
factors for the population being managed. This linked
database for an unselected primary care cohort of
patients with COPD within Lothian is unique within
Scotland. The advantage of population-based data is that
they reﬂect the mix of patients in the population and
the different patient pathways. The cohort characteristics
and hospitalisation rate are similar to other population-
based cohorts of patients with COPD.4 16 Our ﬁndings
should be generalisable to other UK primary care
populations.
Using routine data for research has some limitations.
Although coding of main condition in SMR data has
Table 3 Associations between patient characteristics at diagnosis of COPD in primary care and time to first hospital
admission for acute exacerbation of COPD
Characteristic at diagnosis of
COPD in primary care Level
Risk of first admission
Unadjusted HR
(95% CI) p Value
Fully adjusted HR
(95% CI)* p Value
Age (years) Increase of 1 SD
(11.4 years)
1.42 (1.35 to 1.49) <0.0001 1.31 (1.23 to 1.39) <0.0001
Sex Female 1.06 (0.97 to 1.17) 0.21 0.99 (0.90 to 1.09) 0.82
Deprivation Quintile 1 (most
deprived)
1.00 0.003 1.00 0.0002
Quintile 2 0.96 (0.85 to 1.08) 0.89 (0.79 to 1.01)
Quintile 3 0.80 (0.70 to 0.92) 0.76 (0.66 to 0.87)
Quintile 4 0.80 (0.68 to 0.93) 0.80 (0.68 to 0.93)
Quintile 5 (least
deprived)
0.84 (0.71 to 1.01) 0.74 (0.62 to 0.89)
COPD severity (% predicted
forced expiratory volume)
Mild 1.00 <0.0001 1.00 <0.0001
Moderate 1.43 (1.17 to 1.75) 1.44 (1.18 to 1.76)
Severe 2.89 (2.37 to 3.54) 2.44 (1.99 to 2.99)
Very severe 4.55 (3.60 to 5.75) 3.33 (2.63 to 4.22)
Unknown 2.41 (1.93 to 3.01) 1.64 (1.30 to 2.06)
Body mass index (kg/m2) Normal 1.00 <0.0001 1.00 <0.0001
Low 1.61 (1.37 to 1.89) 1.47 (1.25 to 1.73)
High 0.79 (0.69 to 0.89) 0.83 (0.73 to 0.94)
Unknown 2.32 (2.04 to 2.64) 2.39 (2.09 to 2.74)
Smoking status Current 1.00 0.011 1.00 <0.0001
Not current 1.11 (1.00 to 1.22) 0.86 (0.78 to 0.96)
Never smoked 0.71 (0.52 to 0.96) 0.47 (0.35 to 0.65)
Unknown 1.18 (0.89 to 1.55) 0.70 (0.52 to 0.94)
Asthma comorbidity 1.11 (0.97 to 1.26) 0.12 1.12 (0.97 to 1.28) 0.11
Other respiratory comorbidity 2.28 (1.96 to 2.64) <0.0001 1.47 (1.26 to 1.72) <0.0001
Non-respiratory comorbidity 1.53 (1.39 to 1.68) <0.0001 1.39 (1.24 to 1.55) <0.0001
Prior admission with COPD 2.67 (2.42 to 2.95) <0.0001 1.94 (1.75 to 2.17) <0.0001
Prior intervention for COPD 1.38 (1.26 to 1.52) <0.0001 1.22 (1.10 to 1.36) 0.0002
The HRs are from Cox proportional hazards models for time to admission since diagnosis of COPD in primary care.
*Adjusted for all variables in the table.
COPD, chronic obstructive pulmonary disease.
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been shown to be over 90% accurate in Lothian hospi-
tals,17 the accuracy of primary care data is unknown. It is
also possible that patients have been coded as having
COPD without meeting the spirometric criteria for
inclusion on a disease register. These disease register cri-
teria were introduced in 2004 with spirometric conﬁrm-
ation of diagnosis being incentivised. The issue of
missing primary care data was problematic in this study.
Missing measurements in primary care may reﬂect poor
recording, less intensive management or lack of patient
engagement. Smoking status, BMI and per cent pre-
dicted FEV1 were not missing at random in this cohort.
However, residual confounding from missing data (BMI,
smoking status or % predicted FEV1) is unlikely as the
associations persisted after excluding missing data (data
not shown).
It was not possible to investigate variables that are not
recorded routinely, such as support from carers and
family members, which may affect admission risk.
Practice, hospital and geographic factors may also inﬂu-
ence admission to hospital.18–21 However, once patient
factors were adjusted for, adjustment for practice effects
made little difference to our results and travel time to
hospital (data not shown) was not associated with risk of
admission. Our analysis did not take account of primary
care interventions, such as inﬂuenza vaccination, that
might affect risk of hospital admission for AECOPD.
Time-dependent analysis is required to investigate this,
to avoid introducing immortal time bias, but this was not
possible in the standard PWP model for readmission. In
a separate analysis (data not shown), we used a time-
dependent Cox model to investigate interventions asso-
ciated with risk of ﬁrst AECOPD admission, but as we
were unable to adjust fully for confounding by indica-
tion, the results were inconclusive. Further work is
required to determine whether primary care interven-
tions can reduce the risk of AECOPD admission.
The start of follow-up for our analysis was date of diag-
nosis in primary care. Almost half of the patients had
been treated for respiratory disease prior to this date of
diagnosis and one-ﬁfth of the cohort had a COPD
admission prior to diagnosis. We included ‘COPD admis-
sions before diagnosis’ as a variable, rather than exclude
these patients, as the aim of this study was to look at
characteristics of a ‘real-world’ primary care population.
The deﬁnition of an admission for COPD prior to diag-
nosis was not limited to exacerbations, but also included
any COPD diagnostic code, unlike admissions for
AECOPD after diagnosis.
In our study, 10% of readmissions occurred within
14 days of previous discharge. However, we did not
count these as new readmissions in accordance with
published guidance on using hospital records to deﬁne
new episodes of COPD exacerbations.22
We found that more severe disease, as deﬁned by the
value of % predicted FEV1, had the strongest association
with increased risk of both ﬁrst AECOPD admission and
readmission. Association between % predicted FEV1 and
admissions has been shown in other studies,4 6 9
although not all.8 Increasing age has been identiﬁed as
a risk factor for hospital admission in some studies6 but
again not all.5 8 9 We found that older age at diagnosis
was associated with an increased risk of ﬁrst AECOPD
admission but not for readmission.
Compared with patients with BMI in the normal
range, low BMI was associated with increased risk of ﬁrst
AECOPD admission; whereas high BMI was associated
with decreased risk of ﬁrst AECOPD admission and
readmission. Low BMI is recognised as a marker of more
severe disease and has been identiﬁed as a risk factor in
some6 23 but not all studies.5 The ‘obesity paradox’
whereby patients with COPD with high BMI have better
Figure 1 Cumulative risk of successive hospital admission
for acute exacerbation of chronic obstructive pulmonary
disease (COPD). For first admission, time 0 is the date of
primary care COPD diagnosis. For subsequent admissions,
time 0 is the date on which the patient was considered to
become at risk of readmission, which we have defined as
14 days after the date of discharge of the previous acute
exacerbation of COPD admission.
Table 4 Median time to first admission since diagnosis of
COPD in primary care or median time to each subsequent
admission since start of at risk period after previous
admission
Admission Median time (months) 95% CI
1st Undefined*
2nd 22.0 (20.0 to 24.5)
3rd 8.7 (7.7 to 10.9)
4th 7.0 (5.6 to 9.1)
5th 5.2 (4.0 to 6.5)
6th 4.3 (3.2 to 6.3)
7th 3.5 (2.8 to 4.6)
8th 2.8 (2.0 to 4.4)
9th 1.8 (1.3 to 3.8)
10th 1.5 (1.1 to 4.0)
*<50% experience event.
COPD, chronic obstructive pulmonary disease.
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outcomes (lower all cause mortality and reduced hos-
pital readmission) has been seen by others,6 24 particu-
larly for more severe disease.25 However, the
mechanisms underlying the apparent beneﬁt of high
BMI in COPD have yet to be elucidated.26
Comorbidities are prevalent in patients with COPD.27
We found that respiratory conditions other than asthma
and non-respiratory comorbidities were associated with
an increased risk of ﬁrst admission but not subsequent
admission. A previous hospital-based study found
respiratory comorbidities to be associated with increased
risk of readmission.8 However, other studies, in line with
our ﬁndings, have not shown an association between
comorbidities and risk of COPD readmission.9 28 29
The association of deprivation with emergency admis-
sions in general has been well documented but not well
explained.30 A previous study (not using patient-level
data) showed that deprivation was independently asso-
ciated with COPD admission.18 Why deprivation remains
a signiﬁcant risk factor in our adjusted model for ﬁrst
AECOPD admission should be further explored. It may
be evidence of the inverse care law.31 More deprived
populations may be less well engaged with primary care;
perhaps they seek help later in the disease course, or
perhaps they are less likely to get an appointment to be
assessed for an acute exacerbation.
In univariate analysis, not currently smoking was asso-
ciated with an increased risk of ﬁrst AECOPD admission
compared with current smoking. However, once other
factors were adjusted for, this association was reversed and
patients recorded as not currently smoking had a lower
risk of ﬁrst AECOPD admission compared with current
smokers. There was no association with subsequent admis-
sions. There is limited existing evidence for smoking cessa-
tion reducing risk of COPD hospitalisation.32 Other
studies have found no association between smoking and
hospitalisation risk,5 8 or have found decreased risk in
smokers, probably due to reverse causality.33
Other studies have shown that having a previous
admission for AECOPD or respiratory disease increased
the risk of a subsequent AECOPD admission.6 9 We
found that there was not only an increased risk of a
Table 5 Associations between characteristics at diagnosis of COPD in primary care and times to 2nd to 10th hospital
admissions for AECOPD
Characteristic at diagnosis of
COPD in primary care Level
Risk of readmission (2nd to 10th)*
Unadjusted HR
(95% CI) p Value
Fully adjusted HR
(95% CI)† p Value
Age (years) Increase of 1 SD
(11.4 years)
1.02 (0.97 to 1.07) 0.49 1.02 (0.97 to 1.08) 0.42
Sex Female 0.95 (0.87 to 1.04) 0.27 0.97 (0.89 to 1.07) 0.57
Deprivation Quintile 1 1.00 0.23 1.00 0.27
Quintile 2 0.92 (0.83 to 1.03) 0.94 (0.84 to 1.04)
Quintile 3 0.91 (0.80 to 1.04) 0.94 (0.82 to 1.08)
Quintile 4 0.94 (0.81 to 1.09) 0.97 (0.84 to 1.13)
Quintile 5 0.81 (0.67 to 0.99) 0.80 (0.65 to 0.98)
COPD severity (% predicted
forced expiratory volume)
Mild 1.00 <0.0001 1.00 <0.0001
Moderate 1.19 (0.96 to 1.47) 1.19 (0.95 to 1.47)
Severe 1.42 (1.15 to 1.76) 1.39 (1.12 to 1.72)
Very severe 1.78 (1.42 to 2.22) 1.75 (1.39 to 2.19)
Unknown 1.59 (1.26 to 2.01) 1.44 (1.14 to 1.83)
Body mass index (kg/m2) Normal 1.00 0.003 1.00 0.021
Low 1.10 (0.94 to 1.29) 1.10 (0.93 to 1.30)
High 0.86 (0.75 to 0.98) 0.87 (0.76 to 0.99)
Unknown 1.03 (0.92 to 1.16) 1.01 (0.89 to 1.13)
Smoking status Current 1.00 0.23 1.00 0.46
Not current 1.02 (0.93 to 1.12) 0.99 (0.90 to 1.10)
Never smoked 0.79 (0.51 to 1.23) 0.78 (0.50 to 1.23)
Unknown 1.25 (0.97 to 1.61) 1.17 (0.89 to 1.53)
Asthma comorbidity 1.10 (0.98 to 1.23) 0.11 1.11 (0.98 to 1.26) 0.087
Other respiratory comorbidity 1.21 (1.06 to 1.37) 0.004 1.12 (0.98 to 1.28) 0.11
Non-respiratory comorbidity 0.99 (0.90 to 1.09) 0.85 0.99 (0.89 to 1.09) 0.79
Prior admission with COPD 1.34 (1.23 to 1.47) <0.0001 1.32 (1.20 to 1.45) <0.0001
Prior intervention for COPD 1.09 (1.00 to 1.19) 0.053 1.06 (0.96 to 1.16) 0.23
The HRs are from Prentice-Williams-Peterson models for time to admission since start of at risk period for admission with common regression
coefficient(s) across the admission strata.
*Patients were deemed ‘at risk’ of further AECOPD admission from 14 days after the date of discharge of the Continuous Inpatient Stay in
which the previous exacerbation occurred.
†Adjusted for all variables in the table.
AECOPD, acute exacerbation of COPD; COPD, chronic obstructive pulmonary disease.
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readmission after a ﬁrst AECOPD admission, but also
that having a COPD admission prior to diagnosis in
primary care was independently associated with an
increased risk of both ﬁrst AECOPD admission and
readmission. It is plausible that earlier diagnosis in
primary care reduces the risk of AECOPD admission
and readmission: patients older at diagnosis, with more
severe disease at diagnosis, and who have had admissions
or been treated prior to diagnosis had an increased risk
of admission in our study. This increased risk could be a
reﬂection of a more prolonged disease course and/or
that prompt coding is important for appropriate disease
management. COPD is a progressive disease; diagnosis
and coding in primary care will vary between patients.
However, the Quality and Outcomes Framework (QOF),
the UK pay for performance scheme introduced in
2004, should have incentivised timely coding. QOF
disease registers are based on diagnostic codes and are
required for disease management and GP payment. For
patients diagnosed after the introduction of the QOF
(data not shown), the proportion of patients with COPD
admissions prior to diagnosis was 3% lower, though
admission prior to primary care diagnosis was still signiﬁ-
cantly associated with a risk of ﬁrst admission (HR 2.25,
95% CI 1.90 to 2.66; p<0.0001).
The identiﬁcation of modiﬁable patient characteristics
associated with risk of ﬁrst AECOPD admission after diag-
nosis in primary care can help GPs identify those most at
risk. Maintaining a healthy BMI, stopping smoking and
managing COPD to slow FEV1 decline could all delay an
admission for AECOPD. Being aware of non-modiﬁable
patient risk factors associated with increased risk of
AECOPD admission could also help target patient groups
for disease management, for example, those who are
older, who have more severe disease at diagnosis, more
comorbidities, greater deprivation or admissions before
diagnosis. This study also demonstrates the importance of
early diagnosis of COPD, that is, before an AECOPD
admission and before decline of FEV1.
CONCLUSIONS
While several patient characteristics were associated with
the risk of ﬁrst AECOPD admission after diagnosis,
fewer were found to be associated with the risk of
readmission for this primary care population. The risk
of readmission accelerated with subsequent admission.
Prompt diagnosis in primary care may reduce the risk of
AECOPD admission and readmission. The study high-
lights the important role of primary care in preventing
or delaying a ﬁrst AECOPD admission.
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